Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Molecular Pharmaceutics
|
July 26, 2023
Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection
Asuka Takanashi, Colin W Pouton, Hareth Al-Wassiti
Scientific Reports
|
May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticles
Meagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Pharmaceutics
|
November 13, 2020
The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles
Danijela Zukancic, Estelle J A Suys, Emily H Pilkington, et al.
Biomaterials Science
|
April 27, 2022
<i>In vivo</i> delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression
Azizah Algarni, Emily H Pilkington, Estelle J A Suys, et al.
Nature Communications
|
June 18, 2021
Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay
Serena L Y Teo, Joshua J Rennick, Daniel Yuen, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2020
Assessing the cellular toxicity of peptide inhibitors of intracellular protein-protein interactions by microinjection
Sanjeevini Babu Reddiar, Hareth Al-Wassiti, Colin W Pouton, et al.
Biomacromolecules
|
June 26, 2024
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles
Xie He, Thomas J Payne, Asuka Takanashi, et al.
Ebiomedicine
|
February 16, 2025
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4<sup>+</sup> T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis
Hannah Lukeman, Hareth Al-Wassiti, Stewart A Fabb, et al.
Acta Biomaterialia
|
June 21, 2021
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H Pilkington, Estelle J A Suys, Natalie L Trevaskis, et al.
Ebiomedicine
|
November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Molecular Pharmaceutics
|
July 26, 2023
Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection
Asuka Takanashi, Colin W Pouton, Hareth Al-Wassiti
Scientific Reports
|
May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticles
Meagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Pharmaceutics
|
November 13, 2020
The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles
Danijela Zukancic, Estelle J A Suys, Emily H Pilkington, et al.
Biomaterials Science
|
April 27, 2022
<i>In vivo</i> delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression
Azizah Algarni, Emily H Pilkington, Estelle J A Suys, et al.
Nature Communications
|
June 18, 2021
Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay
Serena L Y Teo, Joshua J Rennick, Daniel Yuen, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2020
Assessing the cellular toxicity of peptide inhibitors of intracellular protein-protein interactions by microinjection
Sanjeevini Babu Reddiar, Hareth Al-Wassiti, Colin W Pouton, et al.
Biomacromolecules
|
June 26, 2024
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles
Xie He, Thomas J Payne, Asuka Takanashi, et al.
Ebiomedicine
|
February 16, 2025
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4<sup>+</sup> T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis
Hannah Lukeman, Hareth Al-Wassiti, Stewart A Fabb, et al.
Acta Biomaterialia
|
June 21, 2021
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H Pilkington, Estelle J A Suys, Natalie L Trevaskis, et al.
Ebiomedicine
|
November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
Page
of 1